Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Predicted Market Size Trajectory For The Respiratory Devices And Equipment (Diagnostic) Market From 2025 To 2034?
The global market for respiratory diagnostic devices and apparatus has experienced robust expansion over the past few years, projecting an increase from $7.81 billion in 2024 to $8.36 billion in 2025, demonstrating a consistent compound annual growth rate (CAGR) of 7.0%; this historical upward trajectory is fueled by several key drivers, including the prevalence of ongoing respiratory illnesses, the demographic shift towards an older populace, widespread tobacco use, ecological influences, and ongoing progress in technology.
Anticipation points toward considerable expansion within the domain of respiratory diagnosis tools and apparatus, projecting a market valuation of $12.13 billion by the year 2029, driven by an anticipated compound annual growth rate of 9.8% across the coming years; this upswing is fundamentally fueled by escalating instances of respiratory ailments, the increasing adoption of telemedicine solutions alongside remote surveillance capabilities, the push toward bespoke medical treatments, and the integrating influence of artificial intelligence and machine learning technologies, while key movements shaping this period encompass advancements in pulmonary function testing protocols, the proliferation of in-home respiratory oversight systems, heightened integration of remote consultation services, and the development of smoking cessation assistance mechanisms.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3376&type=smp
Which Factors And Drivers Are Influencing The Respiratory Devices And Equipment (Diagnostic) Market In 2025?
The rising incidence of a spectrum of respiratory ailments fueled the expansion of the worldwide market for respiratory apparatus and machinery, primarily by necessitating greater utilization of diagnostic tools and gear for both identification and therapeutic intervention. Conditions like chronic obstructive pulmonary disease (COPD), an obstructive pulmonary ailment causing persistent respiratory difficulties, show heightened frequency among older adults. To illustrate the severity, data from the Australian Institute of Health and Welfare, an Australian governmental body, indicated that COPD was responsible for 7,691 fatalities in 2022, equating to 29.6 deaths per 100,000 individuals, and composing 4.0% of all recorded deaths that year. Consequently, this greater volume of instances has propelled the need for diagnostic apparatus and equipment, thereby acting as a catalyst for the advancement of the respiratory devices and equipment market specifically within the diagnostic segment.
What Are The Primary Types Of Segments Analyzed In The Respiratory Devices And Equipment (Diagnostic) Market?
The respiratory devices and equipment (diagnostic)market covered in this report is segmented –
1) By Product: Instruments And Devices, Assays And Reagents
2) By Test Type: Traditional Diagnostic Tests, Mechanical Tests, Imaging Tests, Molecular Diagnostic Tests
3) By Disease Type: Chronic Obstructive Pulmonary Disease, Lung Cancer, Asthma, Tuberculosis, Other Diseases
4) By End User: Hospital/Clinical Laboratories, Physician Offices, Reference Laboratories, Other End Users
Subsegments:
1) By Instruments And Devices: Spirometers, Pulse Oximeters, Peak Flow Meters, Capnographs, Respiratory Pressure Monitors, Portable Ventilators
2) By Assays And Reagents: Diagnostic Kits, Reagents For Respiratory Infections, Blood Gas Analysis Reagents, PCR Assays For Respiratory Pathogens
Which Competitive Trends Are Defining The Respiratory Devices And Equipment (Diagnostic) Market Structure?
There is a noticeable uptrend regarding market participants channeling resources toward diagnostic respiratory equipment that is both wireless and portable, a shift propelled by the inherent advantages of these tools, such as their user-friendliness, economic benefits, sophisticated capabilities, and appropriateness for deployment within home healthcare settings. This burgeoning segment is witnessing the introduction of pioneering, technology-infused portable respiratory solutions, which contrast sharply with older models by offering the immediate assessment of crucial indicators like a patient’s pulse and breathing rhythm right when needed. A concrete example involves a noninvasive portable apparatus, highlighted in May 2024 by the US government entity, the National Center for Biotechnology Information, which furnishes instantaneous findings, thereby establishing itself as indispensable for individuals managing long-term conditions like asthma and COPD; this capacity to deliver swift diagnoses directly wherever the patient resides effectively boosts recovery prospects while concurrently sharpening the overall operational effectiveness of medical services.
Who Are The Major Companies Operating In The Respiratory Devices And Equipment (Diagnostic) Market?
Major companies operating in the respiratory devices and equipment (diagnostic) market include ResMed Inc., Medtronic plc, Masimo Corporation, Fisher & Paykel Healthcare Limited, Koninklijke Philips N.V., Smiths Medical, GE Healthcare, Chart Industries Inc., Philips Healthcare, Becton Dickinson and Company (BD), Abbott Laboratories, Thermo Fisher Scientific Inc., Teleflex Incorporated, Invacare Corporation, Vyaire Medical Inc., Drägerwerk AG & Co. KGaA, Getinge AB, Dräger Medical GmbH, bioMérieux, Bio-Rad Laboratories Inc – Bio-Rad Laboratories Inc., Cosmed S.r.l., Seegene Inc., SDI Diagnostics, GlaxoSmithKline plc, Hillrom, Hamilton Medical AG, Medline Industries Inc., 3M Company, Air Liquide, Allied Healthcare Products Inc., Armstrong Medical, Bio-Med Devices Inc., Breas Medical AB, CAIRE Inc., DeVilbiss Healthcare, Nihon Kohden Corporation, O2 Concepts LLC
Download The Full Report For Exclusive Market Findings:
Which Region Currently Holds The Largest Share Of The Respiratory Devices And Equipment (Diagnostic) Market?
Asia-Pacific was the largest region in the respiratory devices and equipment (diagnostic) market in 2024. North America was the second largest region in the respiratory devices and equipment (diagnostic) market. The regions covered in the respiratory devices and equipment (diagnostic) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Respiratory Devices And Equipment (Diagnostic) Market Report:
https://www.thebusinessresearchcompany.com/customise?id=3376&type=smp
Browse Through More Reports Similar to the Global Respiratory Devices And Equipment (Diagnostic) Market 2025, By The Business Research Company
Respiratory Disease Drugs Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/respiratory-disease-drugs-global-market-report
Veterinary Patient Monitoring Equipment Global Market Report 2025
Generic Pharmaceuticals Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model